stockrowArcus Biosciences, Inc.
RCUS Healthcare Biotechnology
Arcus Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $247.0 million, down 4.26% from fiscal 2024.
- Revenue
- −65.4%
- EPS
- +21.3%
- Free cash flow
- +9.28%
- Total debt
- +4.08%
Quarter to September 2026, against a year earlier
Follow RCUS
Alert me
Arcus Biosciences, Inc. (RCUS) Operating margin
Arcus Biosciences, Inc.'s operating margin over the twelve months to 30 September 2026 was −475.0%, down 318.7 percentage points from fiscal 2025 (−156.3%). Over the past ten years it has ranged from −3,782.1% (fiscal 2017) to 14.1% (fiscal 2021); the current reading is higher than 70% of that period. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −156.3% | (28.37) |
| FY2024 | −127.9% | 162.69 |
| FY2023 | −290.6% | (40.60) |
| FY2022 | −250.0% | (264.10) |
| FY2021 | 14.1% | 173.07 |
| FY2020 | −159.0% | 432.42 |
| FY2019 | −591.4% | 65.37 |
| FY2018 | −656.8% | 3,125.33 |
| FY2017 | −3,782.1% | (3,782.09) |
| FY2016 | 0.00% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | −1,455.6% | (1,221.41) |
| Jun 2026 | −234.2% | 554.09 |
| Mar 2026 | −788.2% | (442.79) |
| Dec 2025 | −345.5% | 200.70 |
| 35 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| MBX MBX Biosciences, Inc. compare | 0.00% |
| PHVS Pharvaris N.V. compare | 0.00% |
| ZLAB Zai Lab Limited Unsponsored ADR compare | −63.0% |
| XNCR Xencor, Inc. compare | −205.8% |
| BEAM Beam Therapeutics Inc. compare | −267.7% |
| RCUS Arcus Biosciences, Inc. | −475.0% |
| RXRX Recursion Pharmaceuticals, Inc. compare | −725.4% |
| NAMS NewAmsterdam Pharma Company N.V. compare | −900.1% |
| IDYA IDEAYA Biosciences, Inc. compare | −1,267.4% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on RCUS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement